Display options
Share it on

Am J Transl Res. 2019 Jun 15;11(6):3412-3425. eCollection 2019.

Multiple facilitated glucose transporters SLC2As are required for normal mouse preimplantation embryo development.

American journal of translational research

Samuel Kofi Arhin, Junzhao Zhao, Xu Ji, Changgeng Shi, Jianan Tang, Yihua Gu, Haitao Xi, Jing Cheng, Xianqin Qu, Huijuan Shi, Xingliang Jin, Jieqiang Lv

Affiliations

  1. Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
  2. Key Laboratory of Contraceptive Drugs and Devices, Shanghai Institute of Planned Parenthood Research Shanghai 200032, China.
  3. Sydney Center for Regenerative and Developmental Medicine, Kolling Institute for Medical Research, Sydney Medical School, University of Sydney St. Leonards 2065, NSW, Australia.

PMID: 31312354 PMCID: PMC6614635

Abstract

BACKGROUND: Glucose metabolism is an essential energy source for mammalian preimplantation embryonic development. Therefore, we aimed to analyze the expression of all 12 known glucose transporters (facilitated solute carrier family 2, Slc2a) during early mouse embryo development.

METHODS: Gene and protein expression of Slc2a transporters in oocytes and embryos were assessed by the TaqMan gene expression assay and confocal immunofluorescence, respectively.

RESULTS: Except for Slc2a2, the other 11 Slc2a transcripts were detected in oocytes. Transcripts of Slc2a1, Slc2a3, Slc2a4, and Slc2a8 were the most enriched and detected in preimplantation embryos. The transcription of other Slc2a isoforms was barely detectable or absent after fertilization; however, they were detected in blastocysts, except for Slc2a10 and Slc2a13. Embryo culture in the simple defined medium caused a reduction in transcription of Slc2a1, Slc2a3, Slc2a4, and Slc2a8 in blastocyst; yet, amino acids partially reversed this impaired transcription of Slc2a1 and Slc2a4. SLC2A1 and SLC2A4 proteins were detected at all embryonic stages with nuclear accumulation in the embryos at the early cleavage stage. SLC2A3 and SLC2A8 were not detected in embryos until the eight-cell stage. The cellular membrane localization of SLC2A1, SLC2A3, and SLC2A8 occurred after compaction and was characterized in blastocysts. SLC2A4 was evenly distributed in the cytoplasm and nuclei without its characteristic membrane localization. Indinavir sulfate (a SLC2A4 inhibitor) decreased the rate of development and prevented glucose utilization in embryos after compaction. These inhibitory activities were partially reversed by exogenous insulin.

CONCLUSION: The results unveil distinct expression patterns of individual Slc2a glucose transporters during early embryo development. Taken together, they provide novel insights into the understanding and management of glucose metabolic infertility in assisted-reproductive technologies (ART).

Keywords: Assisted reproductive technology; SLC2A; gene expression; glucose transporters; preimplantation embryo

Conflict of interest statement

None.

References

  1. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7313-8 - PubMed
  2. Physiol Res. 2000;49(3):347-54 - PubMed
  3. Reprod Fertil Dev. 1999;11(7-8):425-33 - PubMed
  4. Trends Endocrinol Metab. 2001 Mar;12(2):78-82 - PubMed
  5. Semin Reprod Med. 2000;18(2):205-18 - PubMed
  6. Hum Reprod. 2001 Jun;16(6):1229-36 - PubMed
  7. Mol Membr Biol. 2001 Oct-Dec;18(4):247-56 - PubMed
  8. Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E974-6 - PubMed
  9. AIDS. 2002 Apr 12;16(6):859-63 - PubMed
  10. Biochem Cell Biol. 2002;80(5):569-78 - PubMed
  11. Br J Nutr. 2003 Jan;89(1):3-9 - PubMed
  12. Genes Dev. 1992 Jun;6(6):939-52 - PubMed
  13. Endocrinology. 2004 Mar;145(3):1435-43 - PubMed
  14. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15613-8 - PubMed
  15. Endocr Rev. 2004 Apr;25(2):177-204 - PubMed
  16. Anat Embryol (Berl). 2004 Jun;208(3):225-30 - PubMed
  17. Reproduction. 2004 Nov;128(5):503-16 - PubMed
  18. Hum Mol Genet. 2006 Apr 1;15(7):1169-79 - PubMed
  19. Obstet Gynecol. 2006 Sep;108(3 Pt 1):644-50 - PubMed
  20. BMC Dev Biol. 2007 Mar 06;7:14 - PubMed
  21. Biol Reprod. 2008 Apr;78(4):595-600 - PubMed
  22. Biol Reprod. 2008 Jul;79(1):84-92 - PubMed
  23. J Endocrinol. 2009 Jan;200(1):23-33 - PubMed
  24. Ann Anat. 2009 Nov;191(5):485-95 - PubMed
  25. Trends Endocrinol Metab. 2009 Dec;20(10):483-9 - PubMed
  26. Biol Reprod. 2011 Jun;84(6):1216-24 - PubMed
  27. PLoS One. 2011;6(9):e25237 - PubMed
  28. J Anim Sci. 2012 Jul;90(7):2201-10 - PubMed
  29. Biol Reprod. 2012 Aug 30;87(2):49 - PubMed
  30. Endocrinology. 2012 Aug;153(8):3995-4007 - PubMed
  31. J Biol Chem. 2014 Jun 6;289(23):16100-13 - PubMed
  32. Reprod Biol Endocrinol. 2014 May 08;12:35 - PubMed
  33. Reproduction. 2014 Aug;148(2):147-57 - PubMed
  34. Reproduction. 2014 Oct;148(4):429-39 - PubMed
  35. Bioessays. 1993 Apr;15(4):259-64 - PubMed
  36. Biochemistry. 1998 Feb 3;37(5):1322-6 - PubMed
  37. Rev Reprod. 1998 May;3(2):77-81 - PubMed
  38. Am J Physiol. 1998 Jul;275(1):E38-47 - PubMed
  39. J Biol Chem. 1999 Jan 22;274(4):1865-8 - PubMed

Publication Types